# A Trial of SHR0302Base in Patients With Vitiligo

> **NCT06790862** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 155 (actual)

## Conditions studied

- Vitiligo

## Interventions

- **DRUG:** SHR0302Base gel
- **DRUG:** SHR0302Base gel placebo

## Key facts

- **NCT ID:** NCT06790862
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-02-13
- **Primary completion:** 2026-03-03
- **Final completion:** 2026-04
- **Target enrollment:** 155 (ACTUAL)
- **Last updated:** 2026-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06790862

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06790862, "A Trial of SHR0302Base in Patients With Vitiligo". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06790862. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*